You have 9 free searches left this month | for more free features.

Imipenem

Showing 51 - 75 of 146

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Complicated Urinary Tract Infection, Acute Pyelonephritis Trial in Sofia (Sulbactam-ETX2514, Placebo, Imipenem-cilastatin)

Completed
  • Complicated Urinary Tract Infection
  • Acute Pyelonephritis
  • Sofia, Bulgaria
  • +3 more
Jan 20, 2020

Pneumonia, Blood Stream Infection Trial in Worldwide (colistin and meropenem, colistin and )

Completed
  • Pneumonia
  • Blood Stream Infection
  • colistin and meropenem
  • colistin and placebo
  • Miami, Florida
  • +18 more
Nov 3, 2021

Enterobacteriaceae Infections Trial in Spain (Antipseudomonal beta-lactam antibiotic, De-escalation(short-spectrum antibiotic))

Completed
  • Enterobacteriaceae Infections
  • Antipseudomonal beta-lactam antibiotic
  • De-escalation(short-spectrum antibiotic)
  • Jerez de la Frontera, Cádiz, Spain
  • +20 more
Jul 15, 2020

Plasmid Inhibitors and Antimicrobial Drugs Against Clinical

Not yet recruiting
  • Synergy Between Plasmid Inhibitors and Combined Antibiotics
    • (no location specified)
    Jun 27, 2023

    Bariatric Surgery Candidate Trial in Malatya, Sivas (Surgical Site Infection (SSI) prevention package)

    Recruiting
    • Bariatric Surgery Candidate
    • Surgical Site Infection (SSI) prevention package
    • Malatya, Turkey
    • +1 more
    Jun 30, 2023

    Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)

    Not yet recruiting
    • Bronchiectasis
    • +3 more
    • (no location specified)
    Sep 6, 2023

    Endophthalmitis Trial in Paris (Pharmacokinetic and pharmacodynamic study of antibiotics used in severe endophthalmitis from

    Active, not recruiting
    • Endophthalmitis
    • Pharmacokinetic and pharmacodynamic study of antibiotics used in severe endophthalmitis from samples taken from treated patients
    • Paris, Ile-de-France, France
      Groupe Hospitalier Paris Saint Joseph
    Oct 31, 2022

    Antibacterial Prophylaxis, Hematological Malignancies, Allogenetic Hematopoietic Stem Cell Transplantation Trial in Guangzhou

    Unknown status
    • Antibacterial Prophylaxis
    • +3 more
    • Imipenem
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Nov 6, 2018

    Septicemia, Bacterial Infections Trial in Cairo (Tienam 500, Infusion)

    Enrolling by invitation
    • Septicemia
    • Bacterial Infections
    • Tienam 500
    • Infusion
    • Cairo, Egypt
      Ain Shams Univesity Hospital
    Feb 18, 2021

    Antimicrobial Resistance in Hospitals From Meta, Colombia

    Not yet recruiting
    • Increased Drug Resistance
    • Factors associated
    • Villavicencio, Meta, Colombia
      Hospital Departamental de Villavicencio
    Sep 16, 2023

    Pneumonia, Metagenomic Next Generation Sequencing Trial in Changsha (metagenomic next generation sequencing, Conventional

    Unknown status
    • Pneumonia
    • Metagenomic Next Generation Sequencing
    • metagenomic next generation sequencing
    • +2 more
    • Changsha, Hunan, China
      Xiangya Hospital
    Mar 20, 2019

    Use of New Antibiotics in Sweden

    Recruiting
    • Multi-antibiotic Resistance
      • Gothenburg, Sweden
      • +6 more
      Feb 11, 2022

      Febrile Neutropenia Trial in Winston-Salem (Meropenem, Micafungin)

      Not yet recruiting
      • Febrile Neutropenia
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      Mar 13, 2023

      Pseudomonas Aeruginosa in Cystic Fibrosis Trial in United States (TOBI® PODHALER®, TOBI®, Bethkis®)

      Completed
      • Pseudomonas Aeruginosa in Cystic Fibrosis
      • TOBI® PODHALER®
      • +3 more
      • Anchorage, Alaska
      • +46 more
      Mar 7, 2022

      Burns Surgery Trial in Paris (active intervention, intervention)

      Recruiting
      • Burns Surgery
      • active intervention
      • placebo intervention
      • Paris, France
        Saint Louis Hospital
      Aug 8, 2022

      Elimination of Antibiotics During Renal Replacement Therapy and

      Unknown status
      • Critical Illness
      • +2 more
      • Monitoring of antibiotic drug removal
      • Duesseldorf, Germany
        Interdisziplinäre Intensivstation ZOM 1, UKD
      May 6, 2020

      Osteoarthritis, Knee Trial in Leuven (Clinical assessment, Radiographic imaging)

      Active, not recruiting
      • Osteoarthritis, Knee
      • Clinical assessment
      • Radiographic imaging
      • Leuven, Vlaams-Brabant, Belgium
        UZ Leuven
      Aug 17, 2021

      Surgical Site Infection, Antibiotics Prophylaxis Trial in Ibadan (Cefuroxime (Zinnat®), Ceftriaxone (Rocephin®))

      Recruiting
      • Surgical Site Infection
      • Antibiotics Prophylaxis
      • Cefuroxime (Zinnat®)
      • Ceftriaxone (Rocephin®)
      • Ibadan, Oyo, Nigeria
        University College Hospital
      May 27, 2022

      Elimination of Antibiotics During Citrate-anticoagulated

      Unknown status
      • Acute Kidney Injury
      • Bacterial Infection
        • Duesseldorf, Germany
          Prof. Kindgen-Milles
        May 7, 2020

        Nosocomial Infections Trial in Sohag (Silver nanoparticles, Copper nanoparticles)

        Recruiting
        • Nosocomial Infections
        • Silver nanoparticles
        • Copper nanoparticles
        • Sohag, Egypt
          Faculty of medicine - sohag university
        Mar 2, 2021

        Trauma, Resistant Infection, Critical Illness Trial in San Juan (Polymyxin B)

        Unknown status
        • Trauma
        • +2 more
        • Polymyxin B
        • San Juan, Puerto Rico
          Trauma Hospital
        Feb 7, 2019

        In Vitro Activity of Ceftolozane-tazobactam Against Contemporary

        Completed
        • Nosocomial Infection
          • Smolensk, Russian Federation
            The Interregional Association for Clinical Microbiology and Anti
          Dec 16, 2020

          Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by

          Recruiting
          • Beta-lactam
          • +3 more
            • Valenciennes, Nord, France
              Centre Hospitalier de Valenciennes
            Apr 23, 2021

            Resistance to Imipenem and Meropenem at UPMC

            Completed
            • Gram Negative Organism
              • Pittsburgh, Pennsylvania
              • +1 more
              Jun 11, 2018